Diagram showing NAD+/NADH imbalance causing circadian dysfunction, altered metabolism, oxidative stress, inflammation, and genome instability linked to metabolic, cardiovascular, neurodegenerative diseases, aging, and cancer.
📣Announcing July CJPP's #EditorsChoice!
Nampt: a new therapeutic target for modulating NAD+ levels in metabolic, cardiovascular, and neurodegenerative diseases | Manickam et al
📖https://buff.ly/boo7ArZ
🔗https://buff.ly/TkSwoCU
#OpenAccess #Nampt #NAD+ #diabetes #CVD #NeurodegenerativeDisease